Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ABCA7 with biomarker-guided dosing: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Target | Relation | Type | Str |
|---|---|---|---|
| neurodegeneration | promoted: CSF Biomarker-Guided ABCA7 Therapeutic Dosing | disease | 0.62 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| CSF Biomarker-Guided ABCA7 Therapeutic Dosing | 0.619 | neurodegeneration | Why does the V1613M variant reduce amylo |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||